Tissue Therapies Limited ABN 45 101 955 088 Announcement
Biomedical company, Tissue Therapies Limited (ASX: TIS) is very pleased to announce that a new strategic investor has joined the Company’s share register via a private placement. The Board of Tissue Therapies has approved a placement of 3 million Fully-paid Ordinary Shares to this investor at AU$0:37 each, totalling AU$1,110,000, as detailed in the Appendix 3B released to the ASX following this announcement. The new investment will represent approximately 1.7% of the Company’s issued capital.
TIS Price at posting:
41.0¢ Sentiment: None Disclosure: Not Held